Restylane Perlane Lidocaine for Correction of Midface Volume Deficit and/or Midface Contour Deficiency

Midface Volume Deficit Clinical Trial

Official title:
A Randomized, Multi-center, Evaluator-blinded, No-treatment Controlled Study to Evaluate the Efficacy and Safety of Restylane Perlane Lidocaine for Correction of Midface Volume Deficit and/or Midface Contour Deficiency

Status Completed

Clinical Trial Summary

This is a randomized, multi-center, evaluator-blinded, no-treatment controlled study to evaluate the efficacy and safety of Restylane Perlane Lidocaine for correction of Midface Volume Deficit and/or Midface Contour Deficiency.

Clinical Trial Description

n/a

Study Design

Related Conditions & MeSH terms

Midface Volume Deficit

Clinical Trial Details

NCT number	NCT03097783
Study type	Interventional
Source	Galderma R&D
Contact
Status	Completed
Phase	N/A
Start date	April 26, 2017
Completion date	September 14, 2018

View Details

See also
Status	Clinical Trial	Phase
Completed	`NCT04971876` - Evaluation of the Safety and Performance of an Injectable Hyaluronic Acid Filler	N/A
Active, not recruiting	`NCT04132518` - Sculptra for Correction of Midface Volume Deficit and/or Midface Contour Deficiency	N/A
Completed	`NCT03532126` - A 52-week Clinical Investigation of Princess® VOLUME PLUS Lidocaine in Subjects With Midface Volume Deficit
Active, not recruiting	`NCT04784299` - To Evaluate the Performance and Safety of YVOIRE Volume Plus for Improvement of Mid-face Volume	N/A
Completed	`NCT03289052` - Restylane Volyme for Correction of Midface Volume Deficit and/or Midface Contour Deficiency	N/A